Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXFGet Free Report) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 600 shares, a drop of 98.8% from the February 28th total of 48,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. Currently, 0.0% of the company’s stock are sold short.

Nicox Stock Performance

OTCMKTS:NICXF remained flat at $0.25 on Friday. The firm has a fifty day moving average price of $0.25 and a two-hundred day moving average price of $0.31. Nicox has a 1 year low of $0.25 and a 1 year high of $0.28.

About Nicox

(Get Free Report)

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.

Featured Articles

Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.